Aesthetic Business Manager
Galderma
Summary
The role of the Aesthetic Business Manager will implement sales/direct sale plans and processes to maximize sales opportunity through promotion and sale of technical and/or nontechnical products and/or services and solutions directly to current and new end customers.
Job description
Key Responsibilities
- Implement Sales / Direct Sale plans and processes to maximize sales opportunity through promotion and sale of technical and/or nontechnical products and/or services and solutions directly to current and new end customer's
- Track and monitor lead generation plans to ensure a substantive sales opportunity pipeline
- Implement and execute Sales / Direct Sales processes and policies ensuring product/brand sales volumes and profit targets are met
- Collaborate on Sales / Direct Sales activities informing customers of new product/service introductions and prices
Preferred Skills and Qualifications
- Bachelor's Degree required
- 2+ years of combined sales and customer service
- Strategic and consultative sales background
- Prior experience in buy and bill sales
Requirements
- Bachelor's Degree required
- 2+ years of combined sales and customer service
- Strategic and consultative sales background
- Prior experience in buy and bill sales
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Paid Time Off
- Commission Plan
Company overview
Galderma S.A. is a Swiss pharmaceutical company headquartered in Zug, Switzerland, specializing exclusively in dermatology. Founded in 1981 as a joint venture between L'Oréal and Nestlé, the company has evolved into the world's largest independent dermatology company. Galderma focuses on three core business segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. The company offers a comprehensive portfolio of premium brands including Cetaphil, Restylane, Azzalure, Dysport, and Sculptra, serving patients and consumers in over 100 countries. With approximately 6,500 employees globally, Galderma maintains a strong research and development presence across six sites worldwide. The company went public in 2024 with an IPO on the SIX Swiss Exchange, marking a significant milestone in its growth trajectory. Galderma's mission is to advance dermatology for every skin story, combining scientific innovation with trusted partnerships with healthcare professionals to deliver superior outcomes for diverse skin needs.